Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Andrea Natale

Clinical Cardiac Electrophysiology Austin, TX Medical Doctor

NPI 1841382421 CMS profile 129338

3000 N. Ih-35, Suite 700, Austin, TX 78705

Open in the dashboard

General payments

$1,343,292

1,963 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$6,438,734 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Andrea Natale of Austin, TX is reported in the CMS Open Payments database as having received $1,343,292 across 1,963 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $6,438,734 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $368,580 273
2024 General $245,304 337
2023 General $214,274 272
2022 General $208,194 315
2021 General $87,991 263
2020 General $66,085 215
2019 General $152,864 288

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrea Natale
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Andrea Natale were reported at $368,580. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Andrea Natale Clinical Cardiac Electrophysiology median Middle half National median
2019 $152,864 $2,361 $585–$8,260 $163
2020 $66,085 $993 $247–$4,351 $114
2021 $87,991 $1,185 $326–$4,739 $132
2022 $208,194 $2,073 $554–$6,789 $149
2023 $214,274 $2,568 $759–$8,159 $160
2024 $245,304 $2,557 $703–$7,403 $164
2025 $368,580 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $472,904 341 payments
  2. Biosense Webster, Inc. $218,600 651 payments
  3. Medtronic, Inc. $82,614 130 payments
  4. Medical Device Business Services, Inc. $78,471 37 payments
  5. Biotronik Inc. $77,419 61 payments
  6. Itamar Medical Inc $76,413 2 payments
  7. Abbott Laboratories $75,105 427 payments
  8. Volta Medical Inc $66,231 21 payments
  9. Pulse Biosciences, Inc. $42,500 28 payments
  10. Acutus Medical, Inc. $27,854 22 payments
  11. Other $125,181 243 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $640,815 187 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $306,236 79 payments
  3. Travel and Lodging $234,995 289 payments
  4. Food and Beverage $72,042 1,387 payments
  5. Current or prospective ownership or investment interest $38,196 2 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $37,750 7 payments
  7. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $9,600 6 payments
  8. Honoraria $3,500 3 payments
  9. Entertainment $117 1 payment
  10. Education $41 2 payments
Products named General payments · program years 2019–2025
  1. Carto 3 $129,979 455 payments
  2. WATCHMAN FLX $95,355 53 payments
  3. WatchPAT $76,413 2 payments
  4. FARAPULSE Farapulse_Ep $56,345 30 payments
  5. VX1 $49,618 16 payments
  6. FARAPULSE Farapulse_Rm $48,725 13 payments
  7. WATCHMAN Access System $44,778 71 payments
  8. CellFx $42,500 28 payments
  9. General Therapies $38,505 3 payments
  10. Ensite Cardiac Mapping System $28,306 96 payments
  11. Other $385,460 1,057 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 16 drugs

Part D claims

1,116

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$440,616

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

49%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 309 $303,541
Xarelto Rivaroxaban Brand 109 $87,005
Multaq Dronedarone Hcl Brand 47 $42,429
Flecainide Acetate Generic 67 $2,022
Colchicine Generic 55 $1,401
Enoxaparin Sodium Generic 11 $829
Potassium Chloride Generic 105 $736
Metoprolol Succinate Generic 57 $716
Propafenone Hcl Generic 14 $512
Sotalol Sotalol Hcl Brand 35 $402

The 10 drugs with the highest cost, of 16 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 59 billing codes

Paid by Medicare

$361,621

Medicare's payments for the services billed

Medicare patients

511

Average age 75

Services billed

2,011

203 women, 308 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 75%
Arthritis 50%
Ischemic heart disease 46%
Heart failure 37%
Diabetes 19%
Chronic kidney disease 18%
Cancer 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

4 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XARELTO
$783 109 —
DOVATO
$184 — —
Arcalyst
$30 — —
Sotalol Hydrochloride
$10 35 —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

1,963 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record